You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 18, 2024

Details for New Drug Application (NDA): 020850


✉ Email this page to a colleague

« Back to Dashboard


NDA 020850 describes MICARDIS, which is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. Additional details are available on the MICARDIS profile page.

The generic ingredient in MICARDIS is hydrochlorothiazide; telmisartan. There are thirty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; telmisartan profile page.
Summary for 020850
Tradename:MICARDIS
Applicant:Boehringer Ingelheim
Ingredient:telmisartan
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020850
Suppliers and Packaging for NDA: 020850
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MICARDIS telmisartan TABLET;ORAL 020850 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0039 0597-0039-37 3 BLISTER PACK in 1 CARTON (0597-0039-37) / 10 TABLET in 1 BLISTER PACK
MICARDIS telmisartan TABLET;ORAL 020850 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0040 0597-0040-37 3 BLISTER PACK in 1 CARTON (0597-0040-37) / 10 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Nov 10, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength80MG
Approval Date:Nov 10, 1998TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Apr 4, 2000TE:ABRLD:Yes

Expired US Patents for NDA 020850

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim MICARDIS telmisartan TABLET;ORAL 020850-001 Nov 10, 1998 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim MICARDIS telmisartan TABLET;ORAL 020850-002 Nov 10, 1998 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim MICARDIS telmisartan TABLET;ORAL 020850-002 Nov 10, 1998 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim MICARDIS telmisartan TABLET;ORAL 020850-003 Apr 4, 2000 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim MICARDIS telmisartan TABLET;ORAL 020850-002 Nov 10, 1998 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim MICARDIS telmisartan TABLET;ORAL 020850-001 Nov 10, 1998 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim MICARDIS telmisartan TABLET;ORAL 020850-002 Nov 10, 1998 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.